We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
-13.33%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$98.7B
AUM Growth
-$13.4B
Cap. Flow
+$3.55B
Cap. Flow %
3.6%
Top 10 Hldgs %
17.21%
Holding
8,079
New
273
Increased
3,486
Reduced
3,341
Closed
357

Sector Composition

Rank Sector Weight
1 Technology 5.78%
2 Financials 5.08%
3 Healthcare 4.24%
4 Consumer Discretionary 4.16%
5 Energy 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACET icon
6976
Adicet Bio
ACET
$75.3M
$12K ﹤0.01%
13
-6
-32% -$7.9K
ADMA icon
6977
ADMA Biologics
ADMA
$2.02B
$12K ﹤0.01%
5,077
-235
-4% -$1.16K
OSG
6978
CALL
Octave Specialty Group
OSG
$260M
$12K ﹤0.01%
700
-6,300
-90% -$116K
BSVN icon
6979
Bank7 Corp
BSVN
$480M
$12K ﹤0.01%
+917
New +$16K
AXIA
6980
AXIA Energia
AXIA
$23.3B
$12K ﹤0.01%
+2,399
New +$11.4K
EHI
6981
Western Asset Global High Income Fund
EHI
$175M
$12K ﹤0.01%
1,395
-5,658
-80% -$49.3K
ENX
6982
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
$12K ﹤0.01%
1,100
EVG
6983
Eaton Vance Short Duration Diversified Income Fund
EVG
$142M
$12K ﹤0.01%
928
-942
-50% -$12K
FTK icon
6984
CALL
Flotek Industries
FTK
$852M
$12K ﹤0.01%
1,783
+100
+6% +$1.01K
KNDI
6985
Kandi Technologies Group
KNDI
$65M
$12K ﹤0.01%
3,356
-10,040
-75% -$46.2K
MBIO icon
6986
Mustang Bio
MBIO
$4.85M
$12K ﹤0.01%
6
MCR
6987
DELISTED
MFS Charter Income Trust
MCR
$12K ﹤0.01%
1,680
-4,893
-74% -$36.3K
MYN icon
6988
BlackRock MuniYield New York Quality Fund
MYN
$377M
$12K ﹤0.01%
1,000
-715
-42% -$8.11K
PUI icon
6989
Invesco Dorsey Wright Utilities Momentum ETF
PUI
$55.7M
$12K ﹤0.01%
400
QCLN icon
6990
First Trust NASDAQ Clean Edge Green Energy Index Fund
QCLN
$586M
$12K ﹤0.01%
663
-92
-12% -$1.71K
HTT
6991
CALL
High Templar Tech Ltd
HTT
$382M
$12K ﹤0.01%
2,800
-11,300
-80% -$53.9K
TCI icon
6992
Transcontinental Realty Investors
TCI
$372M
$12K ﹤0.01%
449
-42
-9% -$1.36K
PDCO
6993
PUT
DELISTED
Patterson Companies, Inc.
PDCO
$12K ﹤0.01%
+600
New +$14K
VBIV
6994
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$12K ﹤0.01%
259
-2
-0.8% -$110
IHIT
6995
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
$12K ﹤0.01%
1,171
-34
-3% -$340
NMTR
6996
DELISTED
9 Meters Biopharma
NMTR
$12K ﹤0.01%
271
+17
+7% +$1.26K
TBIO
6997
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$12K ﹤0.01%
1,669
-1,072
-39% -$7.85K
NUM
6998
DELISTED
Nuveen Michigan Quality Municipal Income Fund
NUM
$12K ﹤0.01%
1,000
GFY
6999
DELISTED
Western Asset Variable Rate Strategic Fund, Inc
GFY
$12K ﹤0.01%
750
SFLY
7000
PUT
DELISTED
Shutterfly, Inc.
SFLY
$12K ﹤0.01%
300
-4,200
-93% -$221K

Similar funds

Citigroup's Q4 2018 Portfolio in Review

As of Q4 2018, Citigroup held 8,079 positions worth $98.7B, down 12% from $112B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citigroup deployed $3.55B of net new capital in Q4 2018, opening 273 new positions and adding to 3,486 existing holdings. Its largest new stake was Takeda Pharmaceutical: 6,548,306 shares worth $113M.

By sector, the portfolio is most concentrated in Technology at 5.8% of assets, up from 5.1% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.83B trimmed.

  • Citigroup's largest Q4 2018 buy was Takeda Pharmaceutical: 6,548,306 shares worth $113M.
  • Citigroup added most to Energy Transfer Partners in Q4 2018, an estimated $560M increase.
  • Citigroup's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $1.83B.
  • Citigroup fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $677M.
  • Citigroup's ten largest holdings make up 17% of its $98.7B portfolio in Q4 2018.
  • Citigroup opened 273 new positions and closed 357 in Q4 2018.
  • Citigroup's portfolio value fell 12% quarter-over-quarter to $98.7B.

Based on Citigroup's 13F filing for Q4 2018, filed 12 Feb 2019.